CD163 and rheumatoid arthritis: The association between plasma levels of sCD163 and radiographic progression over the years (if the inflammation and the activity of macrophages are not controlled early in RA) underlines the possible role of this biomarker as a disease progression (and possibly its concomitant complications, including cardiovascular disease) predictor.